BioCentury
ARTICLE | Company News

Management tracks: Human Longevity, Clementia

July 13, 2018 10:41 PM UTC

Human Longevity Inc. (San Diego, Calif.) said Chief of Radiogenomics David Karow will become interim CEO and Chief Technology Officer Scott Sorensen will become interim chief operations officer. Karow succeeds J. Craig Venter, who retired in May. Human Longevity no longer lists Saturnino Fanlo, who was COO and CFO, on its website.

Bone disease company Clementia Pharmaceuticals Inc. (NASDAQ:CMTA) said CFO Michael Singer will step down, effective Aug. 9. He is succeeded by Steve Forte, who was CFO of Canadian financial technology firm Thinking Capital Financial Corp...